Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodies
Date Published: 29-Jul-21
Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodies
- Authors: S. Jordan Kerns, Chaitra Belgur, Debora B. Petropolis, View ORCID ProfileRiccardo Barrile, Marianne Kanellias, Johannes Sam, Tina Weinzierl, Tanja Fauti, Anne Freimoser-Grundschober, Jan Eckmann, Carina Hage, Martina Geiger, Patrick Ng, William Tien-Street, Dimitris V. Manatakis, Virginie Micallef, Régine Gerard, Michael Bscheider, Ekaterina Breous-Nystrom, Anneliese Schneider, Anna-Maria Giusti, Cristina Bertinetti-Lapatki, Heather S. Grant, Adrian B. Roth, Geraldine A. Hamilton, Thomas Singer, Katia Karalis, Annie Moisan, Peter Bruenker, Christian Klein, Marina Bacac, Nikolce Gjorevski, View ORCID ProfileLauriane Cabon
- Journal: bioRxiv
- DOI: 10.1101/2021.02.22.432308
- Cited AcceGen Product/Service: Human Pulmonary Alveolar Epithelial Cells
Copyright - Unless otherwise stated all contents of this website are AcceGen™ All Rights Reserved – Full details of the use of materials on this site please refer to AcceGen Editorial Policy – Guest Posts are welcome, by submitting a guest post to AcceGen you are agree to the AcceGen Guest Post Agreement – Any concerns please contact marketing@accegen.com